The board MUST instigate sweeping reforms.
Chief Financial Officer should be the first on the chopping block.
Revenue does however keep growing at a very commendable pace. So all may not be as negative as appears.
Time to focus on margin and the quality of the work being won and the tendering process.
No doubt management are at fault.
Buy in Gloom, sell in Boom.
A decent management team would have this place rocking within 18 months.
Bring out the broom.
- Forums
- ASX - By Stock
- RCR
- chop from the top
RCR
rincon resources limited
Add to My Watchlist
0.00%
!
1.2¢

chop from the top
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.510M |
Open | High | Low | Value | Volume |
1.2¢ | 1.2¢ | 1.2¢ | $9.738K | 811.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 2991811 | 1.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.2¢ | 32500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 2991811 | 0.011 |
4 | 1622323 | 0.010 |
4 | 402222 | 0.009 |
3 | 480000 | 0.008 |
2 | 271430 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 32500 | 1 |
0.013 | 772000 | 2 |
0.014 | 1326174 | 5 |
0.016 | 276029 | 2 |
0.019 | 35117 | 1 |
Last trade - 14.57pm 27/06/2025 (20 minute delay) ? |
Featured News
RCR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online